| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |